You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 10,981,942


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,981,942
Title:Crystalline form of benzylbenzene SGLT2 inhibitor
Abstract:Provided are crystalline forms of a compound having an inhibitory effect on sodium-dependent glucose cotransporter SGLT2. The invention also provides pharmaceutical compositions, methods of preparing the crystalline compound, and methods of using the crystalline compound, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT or SGLT2 inhibition.
Inventor(s):Mengzhuang Cai, Qian Liu, Ge Xu, Binhua Lv, Brian Seed, Jacques Roberge
Assignee:Theracosbio LLC
Application Number:US16/694,642
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,981,942

Introduction

United States Patent 10,981,942, titled "Crystalline form of benzylbenzene SGLT2 inhibitor," is a patent that covers specific crystalline forms of a compound with inhibitory effects on the sodium-dependent glucose cotransporter SGLT2. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent in question pertains to crystalline forms of a benzylbenzene compound, which is used as an SGLT2 inhibitor. SGLT2 inhibitors are a class of drugs used to treat type 2 diabetes by reducing glucose reabsorption in the kidneys.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically outline the specific crystalline forms, their characteristics, and any methods related to their preparation or use.

  • Claim 1: This claim usually defines the broadest scope of the invention, such as the specific crystalline form of the benzylbenzene compound.
  • Claim 2-5: These claims may narrow down the scope by specifying particular characteristics of the crystalline form, such as its X-ray powder diffraction (XRPD) pattern, melting point, or solubility.

Dependent Claims

Dependent claims build upon the independent claims and provide additional specificity. For example:

  • Claim 6: This might specify a method for preparing the crystalline form.
  • Claim 7: This could outline a pharmaceutical composition containing the crystalline form.

Claim Scope and Patent Quality

The scope of the claims is crucial in determining the patent's validity and enforceability. Narrower claims, as discussed in the SSRN paper, are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Patent Scope Metrics

To assess the patent scope, metrics such as independent claim length and independent claim count can be used. These metrics help in understanding the breadth and clarity of the patent claims.

  • Independent Claim Length: Longer independent claims often indicate more complex and specific inventions, which can be beneficial in avoiding infringement but may also increase the risk of being deemed overly broad.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, but it also increases the complexity and potential for litigation[3].

Patent Landscape

Prior Art and Obviousness

The patent landscape includes an analysis of prior art and obviousness. The case of Cytiva BioProcess R&D AB v. JSR Corp. highlights the importance of inherency and prior-art obviousness theories in determining patentability. For U.S. Patent 10,981,942, any prior art related to SGLT2 inhibitors or similar crystalline forms would be crucial in assessing the novelty and non-obviousness of the invention[2].

International Patent Databases

To fully understand the patent landscape, it is essential to search international patent databases. Resources like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to global patent data. This helps in identifying similar patents or applications that could impact the validity or enforceability of U.S. Patent 10,981,942[1][4].

Search Tools and Resources

Several tools and resources are available for conducting a thorough patent search:

  • Patent Public Search: This USPTO tool allows for searching across multiple U.S. patent databases simultaneously[1][4].
  • Global Dossier: This service provides access to file histories of related applications from participating IP Offices, which can be useful in understanding the global patent family[1].
  • PATENTSCOPE: This database offers full-text search capabilities for international PCT applications and patent documents from various national and regional patent offices[4].

Public Search Facilities and Training

For those new to patent searching, resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer trained staff and training materials to assist in conducting thorough searches[1][4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the patent's scope and validity.
  • Patent Scope Metrics: Metrics like independent claim length and count help in assessing the breadth and clarity of the patent.
  • Prior Art and Obviousness: Analyzing prior art and obviousness is essential for determining the novelty and non-obviousness of the invention.
  • International Search: Searching international patent databases is vital for a comprehensive understanding of the patent landscape.
  • Search Tools and Resources: Utilizing tools like Patent Public Search, Global Dossier, and PATENTSCOPE can enhance the search process.

FAQs

  1. What is the main subject of U.S. Patent 10,981,942?

    • The main subject is the crystalline forms of a benzylbenzene compound used as an SGLT2 inhibitor.
  2. How can the scope of a patent be measured?

    • The scope can be measured using metrics such as independent claim length and independent claim count.
  3. What resources are available for conducting a thorough patent search?

    • Resources include the USPTO's Patent Public Search, Global Dossier, PATENTSCOPE, and local Patent and Trademark Resource Centers.
  4. Why is it important to search international patent databases?

    • Searching international databases helps in identifying similar patents or applications globally, which can impact the validity or enforceability of the patent.
  5. What is the significance of prior art and obviousness in patent analysis?

    • Prior art and obviousness are crucial in determining the novelty and non-obviousness of the invention, which are key factors in patent validity.

Sources

  1. USPTO - Search for patents
  2. CAFC - CYTIVA BIOPROCESS R&D AB v. JSR CORP.
  3. SSRN - Patent Claims and Patent Scope
  4. Clemson University - Advanced Patent Searching

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,981,942

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Theracosbio BRENZAVVY bexagliflozin TABLET;ORAL 214373-001 Jan 20, 2023 RX Yes Yes 10,981,942 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 10,981,942

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 121997 ⤷  Try for Free
Australia 2011264220 ⤷  Try for Free
Brazil 112012031616 ⤷  Try for Free
Canada 2800379 ⤷  Try for Free
China 102933592 ⤷  Try for Free
Colombia 6640246 ⤷  Try for Free
Cyprus 1120690 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.